FRANCESCHETTI, Paola
 Distribuzione geografica
Continente #
NA - Nord America 1.343
EU - Europa 613
AS - Asia 290
Totale 2.246
Nazione #
US - Stati Uniti d'America 1.341
DE - Germania 261
CN - Cina 209
UA - Ucraina 120
TR - Turchia 71
IT - Italia 60
RU - Federazione Russa 43
GB - Regno Unito 36
FI - Finlandia 32
SE - Svezia 25
PL - Polonia 18
FR - Francia 12
IN - India 4
VN - Vietnam 3
IR - Iran 2
MX - Messico 2
NL - Olanda 2
RO - Romania 2
CH - Svizzera 1
CZ - Repubblica Ceca 1
MY - Malesia 1
Totale 2.246
Città #
Chandler 195
Jacksonville 135
Fairfield 110
Woodbridge 109
Ashburn 102
Houston 96
Ann Arbor 93
Beijing 67
Izmir 45
Addison 40
Nanjing 40
Wilmington 39
Princeton 33
Cambridge 31
Seattle 31
San Diego 23
New York 22
Milan 21
Shenyang 18
Warsaw 18
Shanghai 14
Bremen 13
Boardman 12
Hebei 12
Nanchang 11
Dearborn 9
Tianjin 9
Changsha 8
Washington 8
Jiaxing 6
San Mateo 6
Ferrara 5
Helsinki 5
Mountain View 5
Zhengzhou 5
Kunming 4
Dong Ket 3
Falls Church 3
Guangzhou 3
Indiana 3
Ningbo 3
Bollate 2
Brembate 2
Cuauhtémoc 2
Des Moines 2
Haikou 2
Hefei 2
Jinan 2
London 2
Orange 2
Verona 2
Amsterdam 1
Arzano 1
Auburn Hills 1
Augusta 1
Bellante 1
Brno 1
Castelnuovo Rangone 1
Cavacurta 1
Chicago 1
Costabissara 1
Dallas 1
Ercolano 1
Ferrara di Monte Baldo 1
Group 1
Hangzhou 1
Hounslow 1
Kalamazoo 1
Lappeenranta 1
Leawood 1
Los Angeles 1
Monmouth Junction 1
Mumbai 1
Norwalk 1
Philadelphia 1
Redwood City 1
San Francisco 1
Selangor 1
Taizhou 1
Tappahannock 1
Trieste 1
Villa Cortese 1
Totale 1.466
Nome #
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 133
Growth hormone and skeletal muscle function 103
Retinoic acid-induced decrease of DNA synthesis and peroxidase mRNA levels in human thyroid cells expressing retinoic acid receptor alpha mRNA. 101
Evidence for androgen receptor gene expression in human thyroid cells and tumours 100
Efficacy and safety of the new 60 mg formulation of the long acting somatostatin analog lanreotide in the treatment of acromegaly. 92
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 91
Diurnal rhythm of plasma catecholamines in acromegaly 90
Endogenous estrogen status significantly influences the nutrition-related alterations in Growth Hormone-Binding protein levles in healthy women 88
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 87
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study 85
Detection of androgen receptor (AR) mRNA by the reverse transcription polymerase chain reaction (RT-PCR) in human thyroids. 81
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 79
Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women 78
Effects of octreotide on gallbladder motor function in acromegaly 78
Sistema Simpatoadrenomidollare nei pazienti acromegalici 77
ADRENAL INCIDENTALOMA: CLINICAL AND METABOLIC ASPECTS DURING LONG-TERM FOLLOW-UP 75
Human galanin reduces plasma norepinephrine levels in man 74
Atypical femoral fractures as a complication of long-term bisphosphonate therapy 68
ASSE GH-IGF-I NELL'INVECCHIAMENTO 68
Expression of all-trans-retinoic acid receptor RNA in human thyroid cells. 68
Efficacy, safety and adherence to treatment of teriparatide: an observational study 67
Follow-up dei pazienti sottoposti a terapia chirurgica per adenomi ipofisari non secernenti. 66
Replacement therapy and quality of life improvement in adult GHD patients 65
Efficay and safety of teriparatide treatment 64
Plasma galanin response to head-up tilt in normal subjects and patients with recurrent vasovagal syncope 61
Bone metastases frequency, distribution, clinical and imaging characteristics in neuroendocrine tumors: our experience 58
Successful treatment with everolimus of functioning liver metastases from a pancreatic insulinoma 57
Bone health in adolescence 31
NEP-Score Thresholds Predict Survival of Patients With Bronchial Carcinoids 30
Correction to: Is the ghost of brown tumor back again? Features of hypercalcaemic primary hyperparathyroidism we must not forget (Endocrine, (2022), 75, 1, (306-308), 10.1007/s12020-021-02896-7) 26
Glucose Metabolism Derangements and Thyroid Nodules: Does Sex Matter? 20
Is the ghost of brown tumor back again? Features of hypercalcaemic primary hyperparathyroidism we must not forget 17
Risk factors for development of atypical femoral fractures in patients on long-term oral bisphosphonate therapy 5
Totale 2.283
Categoria #
all - tutte 8.984
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 879
Totale 9.863


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019187 0 0 0 0 0 0 0 0 27 41 27 92
2019/2020352 80 6 5 42 13 37 20 31 17 59 40 2
2020/2021248 26 12 11 25 9 32 5 30 7 30 47 14
2021/2022297 9 26 12 14 12 9 10 23 7 24 24 127
2022/2023374 35 50 3 60 43 59 19 30 42 4 17 12
2023/2024176 10 24 15 13 22 64 4 20 4 0 0 0
Totale 2.283